<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48766">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02126228</url>
  </required_header>
  <id_info>
    <org_study_id>2ndhsdu-ob</org_study_id>
    <nct_id>NCT02126228</nct_id>
  </id_info>
  <brief_title>no Antibiotics for Elective Cesarean With Low Risk of Infection</brief_title>
  <official_title>A Randomized Controlled Trial on Antibiotics Application For Low Infection-risked Elective Cesarean</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fanzhen Hong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to discuss whether the parturients who underwent elective
      cesarean of such kind do not need prophylactic use of antibiotics and evaluate the risks and
      economic benefits involved.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Temperature</measure>
    <time_frame>3days</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postpartum hemorrhage volume estimates and Routine blood test.</measure>
    <time_frame>3days</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Observation of puerperal infection</measure>
    <time_frame>30days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Incision healing;Intrauterine infection;Pelvic and abdominal infection;Infection of urinary system</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">212</enrollment>
  <condition>Antibiotics , Elective Cesarean, China</condition>
  <eligibility>
    <study_pop>
      <textblock>
        antibiotics group:202 none antibiotics group:212
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective cesarean

          -  With normal temperature;

          -  No signs of infection;

          -  Normal degree of cleanliness in vaginal; .Normal amniotic fluid.

        Exclusion Criteria:

          -  Failure of vaginal delivery and emergency cesarean;

          -  Premature rupture of membranes;

          -  Antibiotics having been applied to 3 days before cesarean;

          -  Having inflammation before cesarean: such as vaginitis, pelvic inflammatory disease,
             chorioamnionitis;

          -  Having infections in respiratory or urinary system before cesarean;

          -  Placenta previa or placental abruption;

          -  With medical and surgical complications;

          -  BMI â‰¥ 30kg/m2;

          -  Total blood loss more than 1000ml within 2 hours after cesarean
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>YONGPING XU, MD.PhD</last_name>
    <role>Study Director</role>
    <affiliation>Obstetrics of 2nd Hospital of Shandong University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>2nd Hospital of Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250033</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Committee opinion no. 465: antimicrobial prophylaxis for cesarean delivery: timing of administration. Obstet Gynecol. 2010 Sep;116(3):791-2. doi: 10.1097/AOG.0b013e3181f68086.</citation>
    <PMID>20733474</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 27, 2014</lastchanged_date>
  <firstreceived_date>April 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shandong University</investigator_affiliation>
    <investigator_full_name>Fanzhen Hong</investigator_full_name>
    <investigator_title>Obstetrics of 2nd Hopital</investigator_title>
  </responsible_party>
  <keyword>antibiotics, cesarean</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
